SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations
THIS SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of August 31, 2012 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and CORIUM INTERNATIONAL, INC., a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENTDevelopment, License and Commercialization Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • New York
This Development, License and Commercialization Agreement (this “Agreement”) is entered into as of October 18, 2006 (the “Effective Date”) between Corium International, Inc., a Delaware corporation having its principal place of business at 2686 Middlefield Road, Redwood City, CA 94063, (“Corium”), and Agile Therapeutics, Inc., a Delaware corporation, having its principal place of business at 366 Wall Street, Princeton, NJ 08540, (“Agile”).
TERM LOAN AGREEMENT dated as of July 13, 2012 between Corium International, Inc. as Borrower, The SUBSIDIARY GUARANTORS from Time to Time Party Hereto, and Capital Royalty Partners II L.P., Capital Royalty Partners II — Parallel Fund “A” L.P. and...Term Loan Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • New York
TERM LOAN AGREEMENT, dated as of July 13, 2012 (this “Agreement”), among Corium International, Inc., a Delaware corporation (the “Borrower”), the SUBSIDIARY GUARANTORS from time to time party hereto and the Lenders from time to time party hereto.
ContractSupply Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • Ontario
[*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION AGREEMENTAnd Commercialization Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • New York
This Development, Manufacturing and Commercialization Agreement (the “Agreement”) is entered into as of May 5, 2004 (the “Effective Date”) between Corium International, Inc., a Delaware corporation having its principal place of business at 2686 Middlefield Road, Redwood City, CA 94063 and its manufacturing operations at 4558 50th Street, S.E., Grand Rapids, MI 49512, including its Affiliates (“Corium”), and Barr Laboratories, Inc., a Delaware corporation, having its principal place of business at 2 Quaker Road, Pomona, New York 10970-0519, including its Affiliates (including but not limited to Duramed Pharmaceuticals, Inc.) (“Barr”).
DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION AGREEMENTAnd Commercialization Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • New York
This Development, Manufacturing and Commercialization Agreement (the “Agreement”) is entered into as of August 14, 2006 (the “Effective Date”) between Corium International, Inc., a Delaware corporation having its principal place of business at 2686 Middlefield Road, Redwood City, CA 94063 and its manufacturing operations at 4558 50th Street, S.E., Grand Rapids, MI 49512, including its Affiliates (“Corium”), and Barr Laboratories, Inc., a Delaware corporation, having its principal place of business at 400 Chestnut Ridge Road, Woodcliff Lake, NJ 07677, including its Affiliates (including but not limited to Duramed Pharmaceuticals, Inc.) (“Barr”).
CORIUM INTERNATIONAL, INC. INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • California
This INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of September 20, 2007, by and among Corium International, Inc., a Delaware corporation (the “Company”), and the individuals and entities (each, an “Investor” and collectively, the “Investors”) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
LICENSE AGREEMENTLicense Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”) is effective as of the 13th day of June, 2005 (the “Effective Date”), between Corium International, Inc. (“Corium”), located at 2686 Middlefield Rd., Suite G, Redwood City, California 94063 and The Procter & Gamble Company (hereinafter along with its Affiliates, referred to as “P&G”) located at One Procter & Gamble Plaza, Cincinnati, Ohio 45202. P&G and Corium may each be referred to as a “Party” and collectively as the “Parties.”
PRODUCT DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENTLicense Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • Florida
THIS PRODUCT DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is made as of May 11th, 2002 (the “Effective Date”), by and between Abrika LLLP, a Florida limited liability limited partnership (“Abrika”), with offices at 3320 Fairfield Lane, Weston, FL 33331, and Corium International, Inc., a Delaware corporation having a place of business at 2686 Middlefield Road, Suite G, Redwood City, CA 94063 (“Corium”; together with Abrika, the “Parties”).
MANUFACTURING AND SUPPLY AGREEMENT FOR TRANSDERMAL FENTANYLManufacturing and Supply Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • Florida
THIS MANUFACTURING AND SUPPLY AGREEMENT (the “Agreement”) is made as of November 12th, 2003 (the “Effective Date”), by and between Abrika LLLP, a Florida limited liability limited partnership (“Abrika”), with offices at 13800 N.W. 2nd St., Suite 190, Florida 33325 and Corium International, Inc., a Delaware corporation having a place of business at 2686 Middlefield Road, Suite G, Redwood City, CA 94063 (“Corium”; together with Abrika, the “Parties”).
AMENDED AND RESTATED SETTLEMENT AGREEMENTSettlement Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • New York
This Amended and Restated Settlement Agreement (the “Agreement”) is entered into and made effective as of November 6, 2012 (the “Effective Date”) by and between Actavis South Atlantic LLC, a Delaware limited liability company having offices at 60 Columbia Road, Morristown, New Jersey 07960 (“Actavis”), and Corium International, Inc., a Delaware corporation having offices located at 235 Constitution Drive, Menlo Park, CA 94025 (“Corium”). Actavis and Corium are each hereafter sometimes referred to as a “Party” and together are referred to as the “Parties” under this Agreement.
LEASELease • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • Michigan
THIS LEASE is made and executed this 5th day of April, 2004, between, FIRCO ASSOCIATES L.L.C., a Michigan limited liability company, of Suite 1, 4380 Brockton SE, Grand Rapids, Michigan 49512, as “Landlord”, and CORIUM INTERNATIONAL, INC. a Delaware corporation, of 4558 — 50th Street SE, Grand Rapids, MI 49512, as “Tenant”.
Assignment and Assumption AgreementAssignment and Assumption Agreement • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • Delaware
This Assignment and Assumption Agreement (the “Agreement”) is dated as of November 6, 2012 by and between ACTAVIS SOUTH ATLANTIC LLC, a Delaware limited liability company (“Assignor”), and PAR PHARMACEUTICAL INC., a Delaware corporation (“Assignee”). This Agreement is subject to, contingent upon, and shall become effective on the date (the “Effective Date”) on which the transactions contemplated in connection with the closing of the Acquisition (as defined below) are consummated.
BUSINESS PARK LEASEBusiness Park Lease • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • California
THIS LEASE is made this 13th day of October, 2006, between DAVID D. BOHANNON ORGANIZATION, a California corporation, herein referred to as “Landlord,” and CORIUM INTERNATIONAL, INC., a Delaware corporation, herein referred to as “Tenant”.
LEASELease • December 23rd, 2013 • Corium International, Inc. • Pharmaceutical preparations • Michigan
THIS LEASE (“Lease”) is made and executed this 30th day of April, 2012, between 4741 Talon Court L.L.C., a Michigan limited liability company, of One Riverfront Plaza, 55 Campau Ave NW, Grand Rapids, Michigan 49503, as “Landlord”, and Corium International, Inc., a Delaware corporation, of 4558 50th Street SE, Grand Rapids, MI 49512, as “Tenant”.
